Total income of the company stood at Rs 7579.99 crore for the year ended March 31, 2016. Total income of the company stood at Rs 2292.94 crore for the quarter ended March 31, 2016. On consolidated basis, the company has posted a net profit after taxes, minority interest and share of profit of associates of Rs 171.48 crore for the quarter ended March 31, 2016. The promoters holding in the company stood at 46.48% while Institutions and Non-Institutions held 41.92% and 11.60% respectively. Glenmark Pharmaceuticals has posted a fall of 24.27% in its net profit at Rs 507.75 crore for the quarter ended March 31, 2016 as compared to Rs 670.43 crore for the same quarter in the previous year.

Source: Mint May 16, 2016 00:48 UTC